glp-1 receptor agonists cardiovascular benefits Effects of Glucagon-Like Peptide-1 Frontiers | The benefits of
Description
Ozempic, a popular brand of a GLP-1 agonist drug, has had multiple lawsuits filed against its manufacturer, Novo Nordisk, for the adverse effects that patients experienced with long-term use

The diabetes GLP-1 market (for type 2 diabetes treatment) similarly shows continued expansion, partly due to new patients being prescribed these powerful agents
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial

These same members lost on average 11.7 percent of body weight after enrollment, a 13x increase in total weight loss

If you're planning pregnancy or currently pregnant, GLP-1 therapy is generally not recommended, and alternative treatments should be discussed
